Andrea Passalacqua

Andrea Passalacqua is an accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as the Vice President and General Manager at Alexion Pharmaceuticals, Inc. in Germany, Andrea leads the country's efforts in the approval, reimbursement, and commercialization of rare disease medicines, while managing cross-functional teams and engaging with various external stakeholders. Previous roles include Vice President of the EU Customer Office at EQRx, General Manager at Oncopeptides AB and bluebird bio, and Business Unit Director at Amgen and Celgene, where Andrea has consistently demonstrated expertise in P&L management, market access, and strategic marketing across multiple therapeutic areas. Educational background includes an MBA from IESE Business School and a Master of Science in Engineering from Sapienza Università di Roma.